HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression

Virus Research

Volumn 121, Issue 2, 2006, Pages 134-143

  Yang, Xiao Jun ^a   Liu, Jing ^a   Ye, Li ^a   Liao, Qing Jiao ^a   Wu, Jian Guo ^a   Gao, Jin Rong ^a   She, Ying Long ^a   Wu, Zheng Hui ^a   Ye, Lin Bai ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cell cycle arrest; Growth inhibition; HCV; NS2 protein

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERO CELL;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CYCLIN A; DOWN-REGULATION; HELA CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; S PHASE; TRANSFECTION; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS; MAMMALIA;

EID: 33748944822     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.02.004     Document Type: Article

References (38)

1. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., and Pestell R.G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270 (1995) 23589-23597
2. Andrecht S., Kolbus A., Hartenstein B., Angel P., and Schorpp-Kistner M. Cell cycle promoting activity of JunB through cyclin A activation. J. Biol. Chem. 277 (2002) 35961-35968
3. Beard M.R., Abell G., Honda M., Carroll A., Gartland M., Clarke B., Suzuki K., Lanford R., Sangar D.V., and Lemon S.M. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology 30 (1999) 316-324
4. Bouchard M., Giannakopoulos S., Wang E.H., Tanese N., and Schneider R.J. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J. Virol. 75 (2001) 4247-4257
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
6. De Francesco R. Molecular virology of the hepatitis C virus. J. Hepatol. 31 Suppl. 1 (1999) 47-53
7. Dumoulin F.L., von dem Bussche A., Li J., Khamzina L., Wands J.R., Sauerbruch T., and Spengler U. Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines. Virology 305 (2003) 260-266
8. Erdtmann L., Franck N., Lerat H., Le Seyec J., Gilot D., Cannie I., Gripon P., Hibner U., and Guguen-Guillouzo C. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J. Biol. Chem. 278 (2003) 18256-18264
9. Franck N., Le Seyec J., Guguen-Guillouzo C., and Erdtmann L. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J. Virol. 79 (2005) 2700-2708
10. Frebourg T., Kassel J., Lam K.T., Gryka M.A., Barbier N., Andersen T.I., Borresen A.L., and Friend S.H. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6413-6417
11. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., and Rice C.M. A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10583-10587
12. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19 (1999) 5785-5799
13. Herber B., Truss M., Beato M., and Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9 (1994) 1295-1304
14. 1-to-S-phase transition. Mol. Cell Biol. 19 (1999) 2690-2698
15. Hong Z., Beaudet-Miller M., Lanford R.E., Guerra B., Wright-Minogue J., Skelton A., Baroudy B.M., Reyes G.R., and Lau J.Y. Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology 256 (1999) 36-44
16. Kalejta R.F., and Shenk T. The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J. Virol. 77 (2003) 3451-3459
17. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R.H., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 (1990) 671-675
18. Kolykhalov A.A., Agapov E.V., Blight K.J., Mihalik K., Feinstone S.M., and Rice C.M. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277 (1997) 570-574
19. Kolykhalov A.A., Mihalik K., Feinstone S.M., and Rice C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74 (2000) 2046-2051
20. Kudoh A., Daikoku T., Sugaya Y., Isomura H., Fujita M., Kiyono T., Nishiyama Y., and Tsurumi T. Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J. Virol. 78 (2004) 104-115
21. Kudoh A., Fujita M., Kiyono T., Kuzushima K., Sugaya Y., Izuta S., Nishiyama Y., and Tsurumi T. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J. Virol. 77 (2003) 851-861
22. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 362-364
23. Lanford R.E., Sureau C., Jacob J.R., White R., and Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202 (1994) 606-614
24. Liang M.H., Geisbert T., Yao Y., Hinrichs S.H., and Giam C.Z. Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis. J. Virol. 76 (2002) 4022-4033
25. Lohmann V., Koch J.O., and Bar tens chlager R. Processing pathways of the hepatitis C virus proteins. J. Hepatol. 24 (1996) 11-19
26. Lopez-Rovira T., Chalaux E., Rosa J.L., Bartrons R., and Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the JunB promoter. J. Biol. Chem. 275 (2000) 28937-28946
27. Murphy E.A., Streblow D.N., Nelson J.A., and Stinski M.F. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J. Virol. 74 (2000) 7108-7118
28. Neddermann P., Tomei L., Steinkuhler C., Gallinari P., Tramontano A., and De Francesco R. The nonstructural proteins of the hepatitis C virus: structure and functions. Biol. Chem. 378 (1997) 469-476
29. Poynard T., Yuen M.F., Ratziu V., and Lai C.L. Viral hepatitis C. Lancet 362 (2003) 2095-2100
30. Santolini E., Pacini L., Fipaldini C., Mgliaccio G., and Monica N. The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J. Virol. 69 (1995) 7461-7471
31. Seeff L.B. Natural history of hepatitis C. Hepatology 26 (1997) 21S-28S
32. Strobeck M.W., Knudsen K.E., Fribourg A.F., DeCristofaro M.F., Weissman B.E., Imbalzano A.N., and Knudsen E.S. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7748-7753
33. Szabo E., Lotz G., Paska C., Kiss A., and Schaff Z. Viral hepatitis: new data on hepatitis C infection. Pathol. Oncol. Res. 9 (2003) 215-221
34. Watanabe G., Albanese C., Lee R.J., Reutens A., Vairo G., Henglein B., and Pestell R.G. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell Biol. 18 (1998) 3212-3222
35. Yamaga A.K., and Ou J.H. Membrane topology of the hepatitis C virus NS2 protein. J. Biol. Chem. 277 (2002) 33228-33234
36. Yanagi M., Purcell R.H., Emerson S.U., and Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8738-8743
37. Yu H., Bauer B., Lipke G.K., Phillips R.L., and Van Zant G. Apoptosis and hematopoiesis in murine fetal liver. Blood 81 (1993) 373-384
38. Zhang H.S., Gavin M., Dahiya A., Postigo A.A., Ma D., Luo R.X., Harbour J.W., and Dean D.C. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101 (2000) 79-89